J. C. Hogg (Vancouver, Canada), A. H. Morice (Cottingham, UK)
A Cochrane review of long-term oxygen therapy for COPD
A. J. Crockett, J. M. Cranston, J. R. Moss, J. H. Alpers (Adelaide, Australia)
|  |
Management of acute exacerbations of COPD in Wycombe, a district general hospital
J. Pickles, S. Cooper, C. G. Wathen (Buckinghamshire, United Kingdom)
| |
Patient and carer preference in two models of care for acute exacerbation of chronic obstructive pulmonary disease: results of a randomized controlled trial
J. C. Ojoo, T. Moon, S. McGlone, K. Martin, M. A. Greenstone, A. H. Morice (Hull, Uxbridge, United Kingdom)
| |
The value of the routine radiographs in patients with exacerbation of COPD
G. Politis, E. Kainis, G. Zarbis, S. Dimopoulou, K. Flevari, C. Chrisiotis, M. Toumbis (Athens, Greece)
| |
Impact of exacerbation on health status deterioration in patients with chronic obstructive pulmonary disease
S. Sato, K. Nishimura, M. Tsukino, T. Oga (Kyoto, Japan)
| |
Specific features of phenotypes of polymorphic haptoglobin system in patients with chronic bronchitis and healthy smokers
E. D. Iantchina, T. V. Ivthcik, N. E. Hodgaynce, A. N. Kokosov, N. V. Kuzmenkova, L. N. Karlova, E. A. Kiseleva, V. V. Lim (Saint-Petersburg, Russia)
| |
Is there a benefit of an additive standard immunoglobulin therapy for the clinical course of COPD patients under chronic immunosuppressive therapy?
J. M. Barth, D. Jaeger, M. Broder (Halle, Marburg, Germany)
| |
Increased levels of histamine in sputum after inhalation of hypertonic saline in patients with COPD
O. Holz, C. Taube, M. Muecke, S. Janicki, K. Paasch, I. Petersen, R. A. Joerres, H. Magnussen (Grosshansdorf, Germany)
| |
FEV1 does not predict the wider disability in patients with COPD referred from primary to secondary care
S. J. Singh, D. Freeman, L. Sewell, M. D. L. Morgan (Leicester, United Kingdom)
| |
A realistic study assessing inhaled treatment compliance in COPD patients
| |
Impaired muscle function in COPD: baseline characteristics of a multicentre intervention and characterization study on Seretide (COSMIC)
E. C. Creutzberg, B. Fokkens, E. F. M. Wouters (Maastricht, Zeist, The Netherlands)
| |
Mortality of patients with emphysema and alpha-1-antitrypsin deficiency of Pi Z phenotype
J. Stolk (Leiden, The Netherlands)
| |
Long-term monitoring of respiratory function and influence of selective beta blockers on its decline in COPD patients with concomitant coronary heart disease
L. I. Kozlova, Z. R. Aisanov, A. G. Chuchalin (Moscow, Russia)
| |
Predictors of high utilization of health care services in patients with chronic obstructive pulmonary disease (COPD)
J. Bourbeau, D. H. Hamd, M. Rouleau, A. Beaupré, F. Maltais, R. Bégin, M. Julien, P. Renzi, D. Nault (Montreal, Canada)
| |
Psychological morbidity among patients admitted with exacerbations of COPD
P. Frith, F. Cheok, R. Antic, J. Alpers, R. Ruffin, B. Smith, A. Southcott, P. Walker (South Australia, Australia)
| |
Improvement of dyspnoea following of six months treatment with tiotropium but not with salmeterol in patients with COPD
V. Brusasco, P. Thompson, W. Vincken, A. Lee, L. Towse, T. J. Witek (Genova, Italy; Nedlands, Australia; Brussels, Belgium; Bracknell, United Kingdom; Ridgefield, United States Of America)
| |
A comparative trial of tiotropium, salmeterol and placebo: health-related quality of life
E. D. Bateman, R. Hodder, M. Miravitlles, A. Lee, L. Towse, C. Serby (Cape Town, South Africa; Ottawa, Canada; Barcelona, Spain; Bracknell, United Kingdom; Ridgefield, United States Of America)
| |
A retrospective audit of chronic obstructive pulmonary disease (COPD) admissions to a university teaching hospital after publication of the British Thoracic Society (BTS) guidelines
M. G. Kelly, J. S. Elborn (Belfast, United Kingdom)
| |
Superior bronchodilation of once daily tiotropium compared to twice daily salmeterol in patients with COPD
J. F. Donohue, J. A. van Noord, S. J. Langley, A. Lee, S. Kesten, L. J. Towse (Chapel Hill, Ridgefield, United States Of America; Heerlen, The Netherlands; Manchester, Bracknell, United Kingdom)
| |
Regular short-acting β2-agonists administration in stable COPD
F. S. F. Ram, P. Sestini, P. W. Jones (London, United Kingdom; Siena, Italy)
| |